Optogenetic system and method
11590357 · 2023-02-28
Assignee
Inventors
- Andrew Jackson (Tyne and Wear, GB)
- Mark Cunningham (Tyne and Wear, GB)
- Stuart Baker (Tyne and Wear, GB)
- Patrick Degenaar (Tyne and Wear, GB)
Cpc classification
A61B5/4836
HUMAN NECESSITIES
A61B5/4094
HUMAN NECESSITIES
A61N2005/0612
HUMAN NECESSITIES
International classification
Abstract
An optogenetic system and method for preventing or halting seizures. The system and method use a sensor for monitoring the activity of a neural network containing a group of target neurons, and generating an input signal indicative of said activity, the target neurons being excitatory neurons. Excitatory stimulation is delivered in the form of an optical signal by an optical stimulator to the target neurons, the optical signal being determined based on the input signal, to reduce the overall activity of the target neurons.
Claims
1. An optogenetic system for preventing or halting seizures by stabilizing brain regions, the system including: a sensor for monitoring an activity of a neural network containing a group of target neurons, and generating an input signal indicative of said activity, the group of target neurons being exclusively excitatory neurons which express optogenetic actuators that cause the cells on which they are expressed to execute excitatory behavior in response to an optical stimulus; an optical stimulator for delivering an excitatory stimulus in the form of an optical signal to the group of target neurons, the optical signal determined based on the input signal, to reduce the overall activity of the group of target neurons; and a processor configured to generate an output signal based on the input signal, wherein the output signal is used to generate the optical signal which forms the excitatory stimulus, wherein: the input signal is oscillatory in nature, and the output signal has the same frequency as the input signal, and wherein the output signal is phase shifted relative to the input signal to provide a phase-shifted optical signal, and the processor is configured to determine or calculate the phase shift, wherein the phase shift is predetermined and fixed, and wherein the processor is configured to calculate the phase shift of the output signal based on the input signal, wherein the processor is configured to identify a range of phases during the oscillation of the input signal at which the delivery of the excitatory stimulus causes a brain region to approach a stable state, and to calculate the phase shift of the output signal based on this identification.
2. The optogenetic system of claim 1, wherein the sensor is located on an implantable device.
3. The optogenetic system of claim 2, wherein the sensor includes an electrode.
4. The optogenetic system of claim 3, wherein the sensor includes an array of electrodes.
5. The optogenetic system of claim 3, wherein the electrode is configured to monitor a local field potential of the neural network containing the target group of neurons.
6. The optogenetic system of claim 1, wherein the optical stimulator is located on an implantable device.
7. The optogenetic system of claim 6, wherein the optical stimulator and the sensor are located on the same implantable device.
8. The optogenetic system of claim 1, wherein the optical stimulator includes a light-emitting element configured to provide light having a light intensity of no less than 0.5 mW/mm.sup.2, and wherein the light emitting element comprises a light emitting diode or a laser.
9. The optogenetic system of claim 8, wherein the optical stimulator includes an array of light-emitting elements.
10. The optogenetic system of claim 1, wherein the input signal is an electrical signal.
11. The optogenetic system of claim 1, wherein the output signal is an electrical signal.
12. The optogenetic system of claim 1, wherein, either: (a) the processor is configured to detect, within the input signal, an event signal which is indicative of an onset or presence of a seizure or seizure-like event, or (b) the sensor is configured to detect an event signal which is indicative of the onset or presence of a seizure or seizure-like event, and to send the input signal, and information relating to the event signal to the processor.
13. The optogenetic system of claim 1, wherein the optical stimulator is configured only to deliver the excitatory stimulus in response to a detection of an event signal.
14. The optogenetic system of claim 13, wherein the processor is configured to generate the output signal only upon the detection of the event signal.
15. The optogenetic system of claim 1, wherein the phase shift is no less than 60° and no more than 165°.
16. The optogenetic system of claim 1, wherein the phase shift is either: (a) no less than −30° and no more than 30°, or (b) no less than 150° and no more than 210°.
17. The optogenetic system of claim 1, wherein the processor is configured to perform band-pass filtering on the input signal, the band-pass filtering having a predetermined filter frequency.
18. The optogenetic system of claim 17, wherein the filter frequency is no less than 1 Hz and no more than 20 Hz.
19. The optogenetic system of claim 1, wherein the processor is configured to perform thresholding and rectification on the input signal, such that an amplitude of the output signal is proportional to an extent to which the input signal exceeds a predetermined threshold.
20. The optogenetic system of claim 1, wherein the output signal is used to control an intensity of the light emitted by the optical stimulator to generate the optical signal which forms the excitatory stimulus.
21. The optogenetic system of claim 1, wherein the output signal is used to modulate a width or frequency of pulses of light, having a constant intensity, to generate the optical signal which forms the excitatory stimulus.
22. A method of halting or preventing seizures by stabilizing brain regions, the method involving the steps of: monitoring an activity of a neural network containing a group of target neurons, the group of target neurons being exclusively excitatory neurons which express optogenetic actuators that cause the cells on which they are expressed to execute excitatory behavior in response to an optical stimulus; generating an oscillatory input signal indicative of the activity; generating an output signal using a processor based on the input signal, wherein the output signal has the same frequency as the input signal, wherein the output signal is phase shifted relative to the input signal to provide a phase-shifted optical signal, and wherein the processor is configured to determine or calculate the phase shift; determining, based on the input-signal, an optical signal for stimulating the group of target neurons, such that when delivered to the group of target neurons, the overall activity of the group of target neurons is reduced; and delivering an excitatory stimulus to the group of target neurons in the form of the optical signal, wherein the phase shift is predetermined and fixed, and wherein the processor is configured to calculate the phase shift of the output signal based on the input signal, wherein the processor is configured to identify a range of phases during the oscillation of the input signal at which the delivery of the excitatory stimulus causes a brain region to approach a stable state, and to calculate the phase shift of the output signal based on this identification.
23. The optogenetic system of claim 1, wherein the group of target neurons are genetically modified to express the optogenetic actuators using a promoter, the promoter being present in excitatory neurons and not present in inhibitory neurons.
24. The optogenetic system of claim 23, wherein the promoter is an EMX promoter.
25. The optogenetic system of claim 24, wherein the promoter is an EMX1 promoter.
26. The optogenetic system of claim 24, wherein the modified gene product is EMX1.
27. The optogenetic system of claim 1, wherein the optogenetic actuators are opsins.
28. The optogenetic system of claim 27, wherein the opsins are Channelrhodopsin 2 (ChR2), Chronos, Chrimson, or ReaChR.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1) Embodiments of the invention will now be described by way of example with reference to the accompanying drawings in which:
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
DETAILED DESCRIPTION
(23)
(24)
(25)
(26) The state space representation of the brain is also useful for understanding what happens during a seizure. This is shown by the non-shaded region with the larger arrows, in
(27) In the present invention, unlike known techniques, the seizures or SLEs are halted or prevented by the application of an excitatory optical stimulus to excitatory neurons. This may seem counter-intuitive, but the mechanism behind such a technique may be best understood with reference to
(28) This phase difference of the excitatory stimulus is shown more clearly in
(29)
(30)
(31)
(32)
(33)
(34)
(35)
(36) Below are described two exemplary sets of experiments, one in vitro and the other in silico that have been conducted by the inventors to demonstrate the phase-dependent modulation of epileptic activity using closed-loop optogenetic stimulation.
Example 1—Phase-Dependent Modulation of In Vitro Epileptic Activity Using Closed-Loop Optogenetic Stimulation
(37) This example considers phase-dependent modulation of epileptic activity using closed-loop optogenetics in rodent brain slices selectively expressing Channelrhodopsins-2 (ChR2) either in excitatory pyramidal neurons using an Emx1 promoter, or in a subset of inhibitory cells using the parvalbumin (PV) promoter.
Experimental Details
(38) Brain Slice Preparation
(39) Coronal neocortical brain slices (400 μm) were prepared from Emx1-ChR2 and PV-ChR2 mice, which provides selective neuronal expression of channelrhodopsin-2 in glutamatergic cells (Gorski et al., 2002.sup.1). The mice were perfused using the same ice-cold oxygenated (95% O2/5% CO2) sucrose-containing artificial cerebrospinal fluid (sACSF) used for cutting the brain slices; (sACSF in mm: 252 Sucrose, 24 NaHCO3, 2 MgSO4, 2 CaCl2, 10 glucose, 3.5 KCl, 1.25 NaH2PO4). Rodent brain slices were cut using a 5100 mz vibratome (Camden Instruments). The slices were later transferred and incubated at room temperature in a brain tissue interface holding chamber until later electrophysiological recordings. During recordings, the slices were perfused with the oxygenated normal ACSF (in mm: 126 NaCl, 24 NaHCO3, 1.2 MgSO4, 1.2 CaCl2), 10 glucose, 3 KCl, 1.25 and NaH2PO4) held at 33-34° C. .sup.1Gorski J A, Talley T, Qiu M, Puelles L, Rubenstein J L, Jones K R (2002) Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. The Journal of neuroscience: the official journal of the Society for Neuroscience 22:6309-6314.
(40) Electrophysiological Recording
(41) To test the proposed closed-loop algorithm in vitro, local field potentials (LFP) from rodent brain slices were recorded, using these to control optical stimulation in a closed-loop manner. All the electrophysiological recordings were performed using an interface recording chamber and 16-channel linear multi-electrode array probe (NeuroNexus Technologies: A16×1-2 mm-100-177 probes—shanks are 100 μm apart; recording site area on each shank, 177). The recording sites on all shanks were located 50 μm from the tip of the electrode. Using this MEA probe, 1500 μm of brain tissue could be sampled at any time either in the same cortical layer or across cortical layers. The impedance of the MEA electrodes used ranged between 0.4-2 MΩ.
(42) LFP signals were amplified using a MP8I headstage and PGA amplifier (Multichannel Systems) with a combined gain of ×1000, and sampled with a Micro1401-3 data acquisition box (CED, UK) at approx. 10 KHz and visualised using Spike2 software running on Windows (Win 7) computer.
(43) Epileptiform Activity Patterns
(44) The convulsant compound 4-aminopyridine (4-AP; 200 μM) was bath applied to induce epileptiform activity in rodent brain slices. Two patterns of spontaneous LFP activity were observed after 4AP application which we have termed ‘interictal activity’ and ‘ictal burst activity’. ‘Interictal activity’ was characterised in the absence of optogenetic stimulation by generally flat LFP with only occasional LFP transients (‘spikes’) which did not develop into oscillations. Note that despite the absence of seizure-like events (SLEs), we call this ‘interictal’ due to the similarity between this pattern and interictal discharges observed in clinical recordings. ‘Ictal burst activity’ was characterised by intermittent LFP transients that developed into SLEs comprising multiple bursts of oscillatory activity. The difference between these patterns likely reflects inherent variability in the animals and/or brain slice preparations.
(45) Closed-Loop Optogenetic Stimulation
(46) Spike 2 software was used to select one of the acquired LFP channels as input to the closed-loop controller (
(47) More specifically, the output of the controller was a 0-5V voltage signal sent to an external LED driver (DC4104; Thorlabs) using the appropriate cable (CAB-LEDD1; Thorlabs). The LED driver was configured such that the 0-5V voltage range was converted to a constant current range of 0-1000 mA. This current drove a blue LED light source (473 nm, M470F1; Thorlabs) coupled to a 200 μm diameter optical fibre (M89L01-200; Thorlabs). The LED driver DC4014 was connected to the LED light source M470F1 via the DC4100-HUB connector hub from Thorlabs. For control experiments, we used a different wavelength of light source (590 nm, 590F2; Thorlabs), which falls outside the activation spectrum of ChR2 opsins.
(48) Closed-Loop Algorithm
(49) The closed-loop algorithm was implemented in custom-designed hardware based around a PIC dsPIC30F4013 microcontroller running at 30 MHz. The microcontroller sampled the LFP signal from one electrode at 500 Hz, applied a phase-shifting finite impulse response (FIR) filter, thresholded (above the background noise level) and half-wave rectified this signal to generate an output which controlled the LED intensity. The FIR filter convolved the input signal with a kernel given by:
e.sup.−kt.Math.cos(2πft+φ)
where k determines the filter band-width and was equal to 1.25; φ determines the extent to which the output is phase-advanced from the input and cycled from 0 to 315° in 45° steps; f determines the center frequency of the pass-band and we used different values in different experiments. In general we chose f to reflect the dominant frequency of ‘ictal burst activity’ (10-20 Hz), and for ‘inter-ictal’ recordings, we chose frequencies between 2-20 Hz. The total kernel length was 512 samples.
(50) Experiments comprised periods of closed-loop stimulation (LED On) and periods of no stimulation (LED Off). For ‘ictal burst recordings’, the duration of these periods was adjusted to ensure that generally at least one spontaneous seizure occurred during each duration.
(51) Analysis
(52) Data were analysed using custom scripts written in Matlab (Mathworks, USA). For ‘interictal activity’, frequency-domain analysis was performed on the entire period of each stimulation condition. For ‘Ictal burst activity’ we analysed only time-periods containing SLEs. The onset of each SLR was identified by an initial threshold crossing below −0.3 mV. Analysis was performed only for a time window of 18 s, chosen to capture the duration of SLEs. In each case, average power spectra for the LFP signal were compiled over the relevant time periods for each condition. Power modulation was calculated as a ratio (in decibels) relative to power during LED Off periods.
(53) In addition, the duration of seizure bursts within SLEs was calculated. The LFP was first high-pass filtered (at 8 Hz) and rectified the LFP. A burst was defined as any time-period for which this signal was not less than 0.1 mV for more than 0.2 s. Bursts with a duration less than 10 ms were excluded. Because the duration of the first burst within the SLE was typically longer than subsequent bursts, these were analysed separately.
Results and Discussion
(54) Excitation of Glutamatergic Pyramidal Neurons During ‘Interictal Activity’
(55) In neocortical slices from Emx1-ChRs mice which did not exhibit spontaneous SLEs (‘interictal activity’), closed-loop optogenetic stimulation could reliably elicit rhythmical LFP oscillations (
(56) In general, these oscillations resulted from a spontaneous large amplitude spike which was fed back by the closed-loop algorithm. We found that the fundamental frequency of the oscillations (and the higher harmonics) increased with increasing phase-shift. Note that by convention we denote positive phase-shifts as a phase-advance of the output relative to the input. Therefore we can alternatively consider that the frequency of oscillation decreased with increasing phase-delay of the (output) optical stimulation relative to the (input) LFP. This makes intuitive sense since the stimulation resulting from a brief LFP spike will resemble the impulse response of the filter. Thus, the peaks of this impulse response (and hence the timing of optical stimulation) will occur later with increasing phase-delay, leading to a slower oscillation. Note also that the amplitude of the induced oscillation varied with stimulation condition, and was greatest when the phase-shift generated a frequency of oscillation that matched the pass-band of the filter, while at other frequencies the closed-loop stimulation did not generate sustained oscillatory activity. However, since the ‘interictal activity’ was characterised by an absence of oscillatory activity in the LED off condition, a general increase in LFP power was observed in all stimulation conditions.
(57) Excitation of Glutamatergic Pyramidal Neurons During ‘Ictal Burst Activity’
(58) Also examined was the effect of closed-loop optical stimulation of pyramidal neurons in the case that spontaneous SLEs were induced by 4-AP.
(59)
(60) The duration of oscillatory bursts within each SLE was also examined. The duration of the first burst within the SLE was either unchanged or extended depending on closed-loop phase-shift (15C). However, the duration of subsequent bursts was suppressed for phase-shifts between 90-180° (15D) (the same conditions associated with a broad reduction in LFP power). In
Example 2—Phase-Dependent Modulation of in Silico Epileptic Activity Using Closed-Loop Stimulation
(61) This example considers computational modelling work that parallels the in vitro closed-loop optogenetic stimulation experiments discussed above.
(62) Methods
(63) Modelling Epileptiform Activity
(64) The model used here is a variant of the classic Wilson-Cowan neural population model [Wilson and Cowan, 1972.sup.3], which is described in detail in previous publications [Wang et al., 2012, Wang et al., 2014.sup.4]. The two-variable version of it is used, which models the neural tissue as a single excitatory population and a single inhibitory population. This model is able to capture epileptiform spikes and epileptiform discharges [Wang et al., 2012.sup.5], which are the two key activity types from the experimental data. .sup.3Wilson, H. and Cowan, J. (1972). Excitatory and inhibitory interactions in localized populations of model neurons. Biophysical Journal, 12(1):1-24.sup.4Wang, Y., Goodfellow, M., Taylor, P. N., and Baier, G. (2014). Dynamic Mechanisms of Neocortical Focal Seizure Onset. PLoS Comput Biol, 10(8):e1003787.sup.5Wang, Y., Goodfellow, M., Taylor, P., and Baier, G. (2012). Phase space approach for modeling of epileptic dynamics. Phys Rev E, 85(6):061918
(65) Briefly, the differential equation system used is:
(66)
where E (I) is the activity of the excitatory (inhibitory) neural population. The parameters a; b; c; d determine how strongly each population influences themselves and the other population. The parameters τ.sub.e and τ.sub.i are time constants, dictating how quickly a population reacts to incoming input.
(67) Finally the sigmoid function is:
(68)
(69) This system will be simulated with noise of amplitude na (reflecting synaptic noise and non-specific input from the surrounding tissue). In other words, the Euler-Maruyama solver can be used to simulate the system as a stochastic differential equation system.
(70) Depending on the parameter settings, the above described system is able to simulate epileptiform interictal spikes, similar to those observed in the in vitro experiments. Essentially, two parameter settings were used, one for the interictal spikes, and one for the ictal discharges. Table 1 lists these in detail for each configuration (interictal vs. ictal) in this example.
(71) TABLE-US-00001 TABLE 1 Interictal Ictal a 17 17 b 15 10 c 40 40 d 0 0 τ.sub.e 0.06 0.0264 τ.sub.i 0.06 0.012 P 0 −0.3 Q −7 −15
(72)
(73) The model outputs (E(t) and I(t)) is suggested to reflect the multi unit activity (MUA) in the in vitro recordings, whereas the local field potential (LFP) is perhaps best modelled as hf.sub.0.1(E+I). The hf( ) function is a high pass filter, in this case with a cut-off frequency of 0.1 Hz. This is to simulate the high-pass filtering properties of the in vitro recording equipment. Such a filter introduced slow waves after the spike, which resembled those observed in the in vitro recording (
(74) Analogous to the modelling of spikes, the system described by equation 1 is capable of producing transient epileptiform ictal discharges, similar to those observed in the in vitro experiments.
(75) Modelling Closed-Loop Stimulation
(76) To model optogenetic input to the system, a simple approach was chosen. The light input is simply added as an additional input term modified by a weight I:
(77)
(78) The detailed dynamics of the Channelrhodopsin [Grossman et al., 2011.sup.10] and the subsequent conversion of this signal to a corresponding postsynaptic potential are simplified here. It is assumed that the LED input is proportional to its equivalent population input. .sup.10Grossman, N., Nikolic, K., Toumazou, C., and Dege-naar, P. (2011). Modeling Study of the Light Stimulation of a Neuron Cell With Channelrhodopsin-2 Mutants. IEEE Transactions on Biomedical Engineering, 58(6):1742-1751
(79) In the experimental closed-loop system, the output of LED(t) is determined by the recorded ongoing activity of the slice. As described earlier, this is currently essentially a phase shifted, rectified version of the filtered recording. In the model, the same algorithm was followed as in the in vitro experiments. In the simulations, the term LED(t) is evaluated at each time point of the Euler-Maruyama algorithm that solves the SDE equations. As the recorded signal (i.e. the simulated LFP), a linear combination of E(t) and I(t) was used, as the real LFP will be a linear combination of population EPSPs and IPSPs, depending on the recording location.
(80) Results
(81) Interictal Spike Activity
(82) The closed-loop stimulation, in vitro, is able to stabilise a single interictal spike into a continuous low frequency oscillations, depending on the phase setting of the stimulation.
(83) It was possible to capture most of the qualitative observations in the in silico model using the same closed-loop stimulation.
(84) The interpretation for these results is fairly simple from a dynamical systems perspective. The fact that such a simple model can capture most experimental observations indicates that the interictal spikes can be understood as an excitable system (near a simple homo-clinic bifurcation). When excited, the system completes one cycle of oscillation.
(85) When using closed-loop stimulation, this oscillation can be stabilised. In dynamical systems terms, we can understand the stimulation as a third coupled variable, and the different phase condition can be understood as the delay of this third variable. In such a framework, it is easy to see that some phases will lead to the stabilisation of the oscillation (i.e. pushing the system beyond the bifurcation point), whereas other phases stabilise the fixed point.
(86) Ictal Burst Activity
(87) The in vitro model displays ictal burst activity, which consists of consecutive periods of beta-range high amplitude oscillatory activity, separated by background activity. During closed-loop stimulation of ictal burst activity in vitro, the essential finding was that the duration of the periods of oscillatory activity is modulated by the phase condition (
(88) The in silico model at the moment is only capturing the periods of beta-range oscillations as separate events. I.e. the periodic bursting is not captured. However, it is possible to test in the simple model the effect of closed-loop stimulation. In the model the phase condition also shows an effect on the duration of the oscillatory events. In certain phase conditions, the event is prolonged by the stimulation. A slight shortening of the oscillations can also be observed at phase 0 (
(89) To quantify this, the mean ictal burst duration is shown for each phase condition in
(90) A possible interpretation of these results is that a simple bistable model of seizure activity is able to capture the prolongation, and shortening of oscillatory activity. In a similar analogy to the interictal case, the prolongation of the oscillation is fairly intuitive.
(91) While the invention has been described in conjunction with the exemplary embodiments described above, many equivalent modifications and variations will be apparent to those skilled in the art when given this disclosure. Accordingly, the exemplary embodiments of the invention set forth above are considered to be illustrative and not limiting. Various changes to the described embodiments may be made without departing from the spirit and scope of the invention.
(92) All references referred to above are hereby incorporated by reference.